• Duphat
  • infinia camp
mededge mea logo web MedEdge_Logo_Dark

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Reading: KFSH Successfully Implements Gene Therapy for Sickle Cell Disease
Share
Notification
  • Duphat
  • infinia camp
mededge mea logo web
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Have an existing account? Sign In
MedEdge MEA > Research > KFSH Successfully Implements Gene Therapy for Sickle Cell Disease
Research

KFSH Successfully Implements Gene Therapy for Sickle Cell Disease

ME Desk
ME Desk
Published: April 3, 2026
Share
2 Min Read
SHARE

April 2026- King Faisal Specialist Hospital & Research Centre (KFSH) successfully applied gene therapy in a patient with sickle cell disease by modifying hematopoietic stem cells to correct the underlying genetic defect, followed by reinfusion of the modified cells, as part of a clinical trial aimed at expanding treatment options for patients ineligible for allogeneic stem cell transplantation.

The milestone reflects KFSHโ€™s ongoing efforts to advance its gene therapy program, bridging clinical care with translational research. By leveraging patient-specific genetic profiles, the hospital is enabling more precise, personalized treatment approaches for complex conditions.

Beyond addressing the root cause of disease, gene therapy has a meaningful impact on patientsโ€™ quality of life. It helps reduce the frequency of painful health crises and minimizes reliance on long-term supportive treatments such as blood transfusions and repeated hospital admissions. This, in turn, supports greater health stability, improved daily functioning, and a lower risk of long-term complications.

Also read: UAE Enables Medical Faculty to Practice, Eases Licensing Requirements for Health Graduates

The delivery of these therapies is supported by a robust clinical and regulatory framework, including comprehensive patient assessments, specialized treatment environments that meet strict safety and quality standards, and seamless collaboration across medical, research, and technical teams. All procedures are carried out in coordination with relevant health authorities and in line with internationally recognized standards.

King Faisal Specialist Hospital & Research Centre has been ranked first in the Middle East and North Africa and 12th globally among the worldโ€™s top 250 Academic Medical Centers for 2026 and recognized as the most valuable healthcare brand in the Kingdom and the Middle East according to Brand Finance 2025. It has also been listed by Newsweek among the Worldโ€™s Best Hospitals 2025, the Worldโ€™s Best Smart Hospitals 2026, and the Worldโ€™s Best Specialized Hospitals 2026.

Click here to join our WhatsApp channel here

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Previous Article WHOOP Raises $575 Million in Series G Round WHOOP Raises $575 Million in Series G Round, Reaches $10.1 Billion Valuation
Next Article MIDAR Signs Agreement with Gruppo GKSD Italy

Recent Posts

  • From market access to national ambition, gulf healthcare is playing a longer game
  • New Push for HIV Innovation and Access Aims to Accelerate Progress Toward 2030 Goals
  • WHO Discusses Digital Health and Humanization of Care at Scientific Conference
  • Rising Ebola Cases Deepen Humanitarian Crisis for Children in DR Congo
  • Burjeel holdings secures dual credit ratings and launches USD 1.5 billion sukuk programme
  • duphat
  • MedEdge-Infinia
Two Point Five Logo white
  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: KFSH Successfully Implements Gene Therapy for Sickle Cell Disease
Share

Published by Two Point Five Media FZCO

  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: KFSH Successfully Implements Gene Therapy for Sickle Cell Disease
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

WhatsApp us

Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?